Company intelligence / Profile preview

Attentive Science

Stilwell, Kansas, USAattentivescience.com ↗

Ownership: Private
Development stage: Other

Overview

Attentive Science does not develop its own therapeutics but provides GLP and nonGLP in-vivo pharmacokinetics, toxicology, and safety pharmacology studies to support drug discovery and development for clients globally. The company has expanded operations internationally, including Australia, to serve biopharma with regulatory-enabling studies for IND submissions. No clinical results are applicable.

Modalities: Small moleculesBiologicsAgrochemicals
Industry: Contract Research Organization

Beyond the preview

Go deeper on Attentive Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Attentive Science.

Explore the full profile